Home › NDC Lookup › RxCUI directory › RxCUI 2623470

Isavuconazonium sulfate 74.5 MG Oral Capsule — RxCUI 2623470

RxNorm drug concept · Semantic clinical drug
RxCUI 2623470 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2623470
Official nameIsavuconazonium sulfate 74.5 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asisavuconazonium sulfate 74.5 MG (isavuconazole 40 MG) Oral Capsule
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)5,727 prescriptions · 27 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Isavuconazonium Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cresemba injection is used to treat two serious fungal infections that can spread deep into the body — invasive aspergillosis (caused by Aspergillus mold) and invasive mucormycosis...
  • What is Cresemba injection actually treating?
  • The IV form of Cresemba is often used when a patient needs treatment right away or isn't able to take oral medications. It must be infused slowly — over at least one hour — through...
  • Why do I need to get it through an IV instead of just taking a pill?
📖 Read our full Isavuconazonium Injection guide →

🕸️ Concept Web — How Isavuconazonium sulfate 74.5 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Isavuconazonium sulfate 74.5 MG Oral Capsule RxCUI 2623470

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Isavuconazonium 1608322
    • Isavuconazonium sulfate 1608321
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cresemba 1608328
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Isavuconazonium Oral Capsule 1608326
    • Isavuconazonium sulfate Oral Capsule 2646713
    • Isavuconazonium Oral Product 1608324
    • Isavuconazonium Pill 1608325
    • Isavuconazonium sulfate Oral Product 2662253
    • Isavuconazonium sulfate Pill 2660933
    • Isavuconazonium Oral Capsule [Cresemba] 1608330
    • Isavuconazonium sulfate Oral Capsule [Cresemba] 2654460
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Isavuconazonium sulfate 74.5 MG SCDC · 2623469
  • Isavuconazonium Oral Capsule SCDF · 1608326
  • Isavuconazonium sulfate Oral Capsule SCDFP · 2646713
  • Isavuconazonium Oral Product SCDG · 1608324
  • Isavuconazonium Pill SCDG · 1608325
  • Isavuconazonium sulfate Oral Product SCDGP · 2662253
  • Isavuconazonium sulfate Pill SCDGP · 2660933

Brand-Name Concepts

  • Isavuconazonium sulfate 74.5 MG Oral Capsule [Cresemba] SBD · 2623472
  • Isavuconazonium sulfate 74.5 MG [Cresemba] SBDC · 2623471
  • Isavuconazonium Oral Capsule [Cresemba] SBDF · 1608330
  • Isavuconazonium sulfate Oral Capsule [Cresemba] SBDFP · 2654460
  • Cresemba Oral Product SBDG · 1608331
  • Cresemba Pill SBDG · 1608332
  • Cresemba BN · 1608328

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2623470 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00469-0420-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0469-0420-01) / 5 mL in 1... CRESEMBA Astellas Pharma US, Inc. 2015-03-06
00469-0520-02 2 BLISTER PACK in 1 CARTON (0469-0520-02) / 7 CAPSULE in 1... CRESEMBA Astellas Pharma US, Inc. 2015-11-04
00469-2860-35 7 BLISTER PACK in 1 CARTON (0469-2860-35) / 5 CAPSULE in 1... CRESEMBA Astellas Pharma US, Inc. 2022-11-22
Observed labelers: Astellas Pharma US, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.